ALPHA: ALitretinoin versus PUVA in severe chronic HAnd eczema trial
The ALPHA trial compares Alitretinoin and PUVA therapy in patients aged 18 years and over with severe hand eczema which is not controlled on a daily (regular) basis with prescription steroid creams. This is to find out which is the most effective treatment:
Both are equally used by doctors in standard clinical practice, but there is no clear evidence indicating which is most effective in treating which type of hand eczema.
BBC Look North (Yorkshire) features Dr Miriam Wittmann discussing the ALPHA trial – click the link http://www.bbc.co.uk/programmes/p03tqv2c to watch the full programme. Here’s a shortened version of the video on the BBC Look North face book page.
We use functional cookies to make our website work and non-functional cookies that provide other services such as analytics. Please indicate which kind of cookies you are willing to allow us to use (you can change your mind later) Allow AllFunctional Only